Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-01-16 @ 1:33 AM
Study NCT ID:
NCT01889420
Status:
TERMINATED
Last Update Posted:
2015-07-31
First Post:
2013-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-26
First Submit QC Date:
None
Study First Post Date:
2013-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-03
Results First Submit QC Date:
None
Results First Post Date:
2015-07-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-03
Last Update Post Date:
2015-07-31
Last Update Post Date Type:
ESTIMATED